Course Description
Hormone therapy plays an important role in psychiatric practice, as these medications can significantly influence mood, cognition, anxiety, sleep, and energy, positioning psychiatric pharmacists to play a key role in supporting safe and effective psychopharmacologic care. This webinar will cover the neuropsychiatric effects of commonly used hormone therapies, reviews potential pharmacokinetic and pharmacodynamic interactions with psychiatric medications, and explores strategies to monitor for emerging or worsening psychiatric symptoms during hormone therapy.
Learning Objectives
- Describe how hormone therapies and fluctuations in estrogen, testosterone, and antiandrogens influence mood, cognition, and anxiety.
- Analyze potential pharmacokinetic and pharmacodynamic interactions between commonly prescribed psychotropics and hormone therapy agents.
- Outline a plan to monitor for and manage psychiatric symptom changes in a patient receiving hormone therapy.
Target Audience
If you are a pharmacist, nurse practitioner, or other health care professional involved in the comprehensive medication management of individuals living with mental health and/or substance use disorders, we invite you to participate in this online course.
Faculty
View biographical information
Carol A. Ott, PharmD, MPH, BCPP, FAAPP
Clinical Professor of Pharmacy Practice; Purdue University
Carol Ott, PharmD, MPH, BCPP, FAAPP is a clinical professor of pharmacy practice in the Purdue University College of Pharmacy and a clinical pharmacy specialist in psychiatry in the Gender Health program at Eskenazi Health. She is a Clinical Professor of Public Health (Courtesy) in the Department of Public Health at Purdue University and an Adjunct Professor of Psychiatry for the Indiana University School of Medicine. Dr. Ott is a member of the Board of Health for Tippecanoe County and serves as the chair of the Tippecanoe Regional Opioid Settlement Community Committee. In Tippecanoe County, she also sits on the Fetal/Infant Mortality Review Team, Suicide and Overdose Fatality Review Team, and Child Protection Team. She serves Indiana Medicaid as a member of the Drug Utilization Review Board, Mental Health Quality Advisory Committee, Therapeutics Committee, and Psychotropic Medication Advisory Committee. Dr Ott is a clinical consultant psychiatric pharmacist for the Indiana University School of Medicine Department of Psychiatry and Indiana Department of Child Services Psychotropic Review partnership for ward and foster children in Indiana. Statewide, Dr Ott sits on the Indiana Maternal Mortality Review Team. Dr. Ott is the faculty advisor for the AAPP Purdue student chapter and in the College of Pharmacy at Purdue and for the Boiler Substance Awareness Network student organization for Purdue University and the John Martinson Honors College at Purdue. For AAPP, Dr. Ott is an editor for the Psychiatric Pharmacy Review Course.
Course Requirements
To receive ACPE credit for this session, you must:
- Register for this course.
- Review the full content of the activity and reflect upon its teachings.
- Complete the evaluation at the end of the activity.
- Provide the necessary details in your profile to ensure correct reporting by AAPP to CPE Monitor.
Continuing Education Credit and Disclosures
Activity Dates: 10/1/2026-10/1/2029
ACPE Contact Hours: 1.25
ACPE Number: 0284-0000-##-###-###-P (Application)
 | The American Association of Psychiatric Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. |
Nursing Credit Reminder: Note that ACPE credit is accepted for ANCC Certification Renewal and AANPCB advanced practice provider content. For specific questions related to your organization's acceptance of ACPE continuing education units, please contact your organization directly.
View Faculty and Program Planning Committee Disclosures of Interest
Faculty: Carol A. Ott, PharmD, MPH, BCPP, FAAPP has nothing to disclose
Planning Committee: Members and disclosures listed here.
View AAPP's Disclaimer and Disclosure Declarations
AAPP Disclaimer: Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Unlabeled Use Disclosure: Faculty of this CME/CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices. CME Outfitters, LLC, the faculty, planners, and American Association of Psychiatric Pharmacists do not endorse the use of any product outside of the FDA labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.
View AAPP's Privacy Policy
AAPP owns the copyright, is licensed or has received permissions for use of, or is otherwise permitted to use copyrighted materials within any CPE activity. Authors and speakers are required to obtain necessary copyright permissions for content in CPE activities. AAPP complies with copyright laws and regulations.
View AAPP's Fair Balance and Integrity Statement
It is the policy of AAPP to ensure independence, balance, objectivity, scientific rigor, and integrity in continuing education activities. Those involved in the development of this continuing education activity have made all reasonable efforts to ensure that information contained herein is accurate in accordance with the latest available scientific knowledge at the time of accreditation of this continuing education activity. Information regarding drugs (e.g., their administration, dosages, contraindications, adverse reactions, interactions, special warnings, and precautions) and drug delivery systems is subject to change, however, and the reader is advised to check the manufacturer’s package insert for information concerning recommended dosage and potential problems or cautions prior to dispensing or administering the drug or using the drug delivery systems.
Fair balance is achieved through ongoing and thorough review of all materials produced by faculty, and all educational and advertising materials produced by supporting organizations, prior to educational offerings. Approval of credit for this continuing education activity does not imply endorsement by AAPP for any product or manufacturer identified.